X-118974911-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000371628.8(LONRF3):c.131A>T(p.Glu44Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000042 in 1,189,989 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000371628.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LONRF3 | NM_001031855.3 | c.131A>T | p.Glu44Val | missense_variant | 1/11 | ENST00000371628.8 | NP_001027026.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LONRF3 | ENST00000371628.8 | c.131A>T | p.Glu44Val | missense_variant | 1/11 | 1 | NM_001031855.3 | ENSP00000360690.3 | ||
LONRF3 | ENST00000304778.11 | c.131A>T | p.Glu44Val | missense_variant | 1/10 | 1 | ENSP00000307732.7 | |||
LONRF3 | ENST00000481285.5 | n.131A>T | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000435426.1 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 113080Hom.: 0 Cov.: 24 AF XY: 0.0000284 AC XY: 1AN XY: 35224
GnomAD3 exomes AF: 0.0000145 AC: 2AN: 137607Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 40225
GnomAD4 exome AF: 0.00000279 AC: 3AN: 1076909Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 348785
GnomAD4 genome AF: 0.0000177 AC: 2AN: 113080Hom.: 0 Cov.: 24 AF XY: 0.0000284 AC XY: 1AN XY: 35224
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.131A>T (p.E44V) alteration is located in exon 1 (coding exon 1) of the LONRF3 gene. This alteration results from a A to T substitution at nucleotide position 131, causing the glutamic acid (E) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at